StemVax: Innovest Global Inc.: Innovest Global Completes Sale of StemVax Therapeutics to NovAccess Global
Innovest Global Receives 7.5 Million Shares of NovAccess Global Common Stock as Consideration for StemVax Therapeutics; Divestiture of Biotech Subsidiary Signals Renewed Focus on Growing Industrial...
Read full article »
StemVax is a biotechnology company that develops and commercializes stem cell-based immunotherapies for the treatment of brain tumor.
Read more